BioMarin Pharmaceutical Inc. · Novato, CA United States (NASDAQ: BMRN)
| 105 Digital Dr. | Phone: 415-506-6700 |
| Novato, CA | Fax: 415-382-7889 |
| 94949 | |
| United States |
BioMarin Pharmaceutical Inc. Rankings
Company Description
BioMarin Pharmaceuticals works to raise orphan drugs up right. The company has developed a number of FDA-approved drugs that qualify for orphan drug status, a financial incentive that encourages companies to create drugs for rare diseases by giving the compounds a period of market exclusivity. BioMarin's Aldurazyme (co-developed with
Financials
| Company Type | Public - NASDAQ: BMRN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 871 |
Executives
61 executives listed for BioMarin Pharmaceutical Inc.'s Novato, CA location.
| Chairman | Pierre Lapalme | |
|---|---|---|
| CEO and Director | Jean-Jacques Bienaimé | |
| SVP and CFO | Jeffrey Cooper |


